PI
BDSX icon

Putnam Investments’s Biodesix BDSX Stock Holding History

Putnam Investments’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,932
Closed -$5.25M – 788
2021
Q1 		$5.25M Sell
12,932
-3,270
-20% -$1.46M 0.01% 488
2020
Q4 		$6.53M Buy
+16,202
New +$5.04M 0.01% 453

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Putnam Investments's BDSX Position: Q2 2021 in Review

Putnam Investments sold out of Biodesix (BDSX) in Q2 2021, closing a stake of 12,932 shares — an estimated $5.25M sold.

Putnam Investments first reported a position in BDSX in Q4 2020 and held it in 2 quarters. The position peaked at $6.53M in Q4 2020. 47 funds tracked by Wall St. Rank hold BDSX as of Q2 2021.

  • Putnam Investments reported no remaining Biodesix position as of Q2 2021 after selling out during the quarter.
  • Putnam Investments sold 12,932 Biodesix shares in Q2 2021, an estimated $5.25M.
  • Putnam Investments first reported a position in Biodesix in Q4 2020 and held it in 2 quarters.
  • Putnam Investments's Biodesix position peaked at $6.53M in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Biodesix as of Q2 2021.

Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.